Parkinson's disease and hospital admissions: frequencies, diagnoses and costs

被引:39
|
作者
Vossius, C. [1 ,2 ,3 ]
Nilsen, O. B. [2 ,4 ]
Larsen, J. P. [1 ,2 ,5 ]
机构
[1] Stavanger Univ Hosp, Dept Neurol, N-4068 Stavanger, Norway
[2] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway
[3] Stokka Teaching Nursing Home, Stavanger, Norway
[4] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway
[5] Univ Bergen, Inst Med, Bergen, Norway
来源
ACTA NEUROLOGICA SCANDINAVICA | 2010年 / 121卷 / 01期
关键词
Parkinson's disease; hospital admissions; costs; QUALITY-OF-LIFE; ECONOMIC-IMPACT; RESOURCE USE; PREVALENCE; BURDEN; STROKE; ILLNESS; COHORT; EXPENDITURES; EPIDEMIOLOGY;
D O I
10.1111/j.1600-0404.2009.01239.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To evaluate the frequencies, causes and costs related to hospital admissions for patients with Parkinson's disease (PD) and controls. Methods - In a prospective cohort study, 108 patients with PD from a population-based prevalence study and 854 age- and sex-matched controls were followed regarding admissions to the Stavanger University Hospital over a period of 12 years. Results - There was no significant difference regarding the number of patients admitted, number of admissions or length of stay between the two cohorts. Based on 2005 prices, the costs per person year of survival were EUR 3288 for patients with PD and EUR 2466 for control individual with incremental costs of EUR 822. However, the difference in costs was not statistically significant. The two cohorts had a different distribution of diagnoses causing hospital admissions. Patients with PD were more often admitted for PD-related symptoms and falls, while vascular disorders and cancer were substantially more common in control individuals. Conclusion - Hospitalization in PD does not induce incremental costs. The diagnoses causing hospital admissions were different in patients with PD as compared with controls. Our results indicate that cancer and vascular diseases might be less common in patients with PD than in the general population.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [31] Parkinson's disease and hospital admissions in the Brazilian National Health System: Epidemiological findings from 2019 to 2020
    Correa, Tulio
    Garcez, Valquiria
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [32] Rising hospital admissions Costs and costing systems
    Gray, Denis J. Pereira
    BRITISH MEDICAL JOURNAL, 2010, 340
  • [33] Analysis of direct costs in the treatment of Parkinson's disease
    Keller, S
    Kessler, T
    Bremen, D
    Jost, W
    MOVEMENT DISORDERS, 2002, 17 : S136 - S136
  • [34] HOSPITAL ADMISSIONS AND ASSOCIATED COSTS OF ALCOHOLIC LIVER DISEASE IN SCOTLAND BETWEEN 1991 AND 2011
    Lewsey, J.
    Blutell, J.
    Geue, C.
    Antony, G.
    Briggs, A.
    McCartney, G.
    Hutchinson, S.
    Graham, L.
    Heydtmann, M.
    GUT, 2016, 65 : A270 - A270
  • [35] DIRECT MEDICAL COSTS OF PARKINSON'S DISEASE IN JAPAN
    Naoi, I
    Baba, K.
    Shibahara, H.
    Inoue, S.
    Aino, H.
    VALUE IN HEALTH, 2021, 24 : S166 - S166
  • [36] Costs of Parkinson’s Disease in a Privately Insured Population
    Scott J. Johnson
    Anna Kaltenboeck
    Melissa Diener
    Howard G. Birnbaum
    ElizaBeth Grubb
    Jane Castelli-Haley
    Andrew D. Siderowf
    PharmacoEconomics, 2013, 31 : 799 - 806
  • [37] TREATMENT COSTS OF PARKINSON'S DISEASE IN CENTRAL EUROPE
    Maresova, Petra
    Klimova, Blanka
    Valis, Martin
    Kuca, Kamil
    Mohelska, Hana
    E & M EKONOMIE A MANAGEMENT, 2016, 19 (03): : 31 - 39
  • [38] Costs of Parkinson's Disease in a Privately Insured Population
    Johnson, Scott J.
    Kaltenboeck, Anna
    Diener, Melissa
    Birnbaum, Howard G.
    Grubb, ElizaBeth
    Castelli-Haley, Jane
    Siderowf, Andrew D.
    PHARMACOECONOMICS, 2013, 31 (09) : 799 - 806
  • [39] Analysis of direct costs in the treatment of Parkinson's disease
    Keller, S
    Kessler, T
    Meuser, T
    Fogel, W
    Bremen, D
    Jost, WH
    NERVENARZT, 2003, 74 (12): : 1105 - +
  • [40] DIRECT MEDICAL COSTS RELATED TO PARKINSON'S DISEASE
    Rodriguez Violante, M.
    Cervantes Arriaga, A.
    Soto Molina, H.
    Diaz Martinez, J. P.
    Pizarro Castellanos, M.
    VALUE IN HEALTH, 2014, 17 (03) : A59 - A59